TECH & INNOVATION

Rolapitant reduces nausea and vomiting in Phase III trial

Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain.

Brains not recognizing an angry expression

Responses of children with attention-deficit/hyperactivity disorder Responses of children with attention-deficit/hyperactivity disorder Inattention, hyperactivity, and impulsive behavior in children with ADHD can result in social problems and they tend to be excluded from peer activities.

Pneumonia bacterium leaves tiny lesions in the heart, study finds

Three institutions collaborate to develop vaccine to treat infection Three institutions collaborate to develop vaccine to treat infection The long-observed association between pneumonia and heart failure now has more physical evidence, thanks to research in the School of Medicine at The University of Texas Health Science Center at San Antonio.

Genetic 'instruction set' for antibodies knocks down hepatitis C in mice

A triple-punch of antibodies both prevented hepatitis C infection and wiped out the disease after it had established itself in laboratory mice, according to a study led by Princeton University researchers. Instead of delivering the three antibodies directly, the researchers administered a genetic "instruction set" that, once in a cell, developed into antibodies that target the portions of the virus that do not mutate.

NOT ALL HISPANICS ARE THE SAME WHEN IT COMES TO DRINKING

Hispanics are often grouped into a single category when it comes to alcohol use. Yet a new Michigan State University study indicates that the risk of alcohol abuse and dependence can vary significantly among different subgroups within the population.

Recommended Stories